News & Analysis on Clinical Trial Services & Contract Research And Development
To improve patient safety and reduce risk, Elsevier is developing an improved drug-drug interaction risk calculator in collaboration with several pharma partners, including Boehringer Ingelheim, Eli Lilly, and Servier.
Almac joins a working group made up of clinical supply chain industry members, in order to contribute to the use case discussion about blockchain technology.
Sandoz has moved to recall all quantities and lots of ranitidine hydrochloride capsules from the US market due to contamination with NDMA.
InsightRX raises $10m in a Series A funding round to further develop its treatment individualization platform and broaden the therapeutic areas in which it’s applicable.
Europe joins the US in giving approval to Epidyolex, a CBD treatment for childhood-onset epilepsy.
UPDATED
Boehringer adopts Inflammasome’s intravitreal drug delivery technology to develop treatments for retinal diseases.